Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension
暂无分享,去创建一个
J. Bosch | R. Deulofeu | J. García‐Pagán | J. Abraldes | P. Bellot | M. Hernández‐Guerra | J. Turnés | J. Turnes
[1] J. Bosch,et al. Increased hepatic resistance: a new target in the pharmacologic therapy of portal hypertension. , 2005, Journal of clinical gastroenterology.
[2] J. García‐Pagán,et al. Bhathal PS, Grossman HJ. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators (J Hepatol 1985; 1: 325–337) , 2004 .
[3] A. Dominiczak,et al. Strategies to reduce oxidative stress in cardiovascular disease. , 2004, Clinical science.
[4] J. Rodés,et al. Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis. , 2004, Gastroenterology.
[5] R. Groszmann,et al. A liver-specific nitric oxide donor improves the intra-hepatic vascular response to both portal blood flow increase and methoxamine in cirrhotic rats. , 2003, Journal of hepatology.
[6] J. Rodés,et al. Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis , 2003, Hepatology.
[7] F. Nevens,et al. Low NO bioavailability in CCl4 cirrhotic rat livers might result from low NO synthesis combined with decreased superoxide dismutase activity allowing superoxide-mediated NO breakdown: A comparison of two portal hypertensive rat models with healthy controls , 2003, Comparative hepatology.
[8] Leslie A. Smith,et al. Long-Term Vitamin C Treatment Increases Vascular Tetrahydrobiopterin Levels and Nitric Oxide Synthase Activity , 2003, Circulation research.
[9] J. Rodés,et al. Cyclooxygenase‐derived products modulate the increased intrahepatic resistance of cirrhotic rat livers , 2003, Hepatology.
[10] M. Kelm,et al. Indexes of NO bioavailability in human blood. , 2002, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.
[11] D. Yadav,et al. Serum and liver micronutrient antioxidants and serum oxidative stress in patients with chronic hepatitis C , 2002, American Journal of Gastroenterology.
[12] V. Desmet,et al. In vivo gene transfer of endothelial nitric oxide synthase decreases portal pressure in anaesthetised carbon tetrachloride cirrhotic rats , 2002, Gut.
[13] P. Pemberton,et al. Oxidative stress in chronic hepatitis C: not just a feature of late stage disease. , 2002, Journal of hepatology.
[14] F. Nevens,et al. Blood antioxidant levels in patients with alcoholic liver disease correlate with the degree of liver impairment and are not specific to alcoholic liver injury itself , 2002, Alimentary pharmacology & therapeutics.
[15] J. Rodés,et al. 5-lipoxygenase inhibition reduces intrahepatic vascular resistance of cirrhotic rat livers: a possible role of cysteinyl-leukotrienes. , 2002, Gastroenterology.
[16] D. Treré,et al. Oxidative Stress EPR Measurement in Human Liver by Radical-probe Technique. Correlation with Etiology, Histology and Cell Proliferation , 2002, Free radical research.
[17] H. Figulla,et al. Reversibility of coronary endothelial vasomotor dysfunction in idiopathic dilated cardiomyopathy: acute effects of vitamin C. , 2001, The American journal of cardiology.
[18] G. Robino,et al. Oxidative stress-related molecules and liver fibrosis. , 2001, Journal of hepatology.
[19] A. Morelli,et al. NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[20] F. Ohsuzu,et al. Impaired endothelium-dependent vasodilation in the brachial artery in variant angina pectoris and the effect of intravenous administration of vitamin C. , 2001, The American journal of cardiology.
[21] E. Werner,et al. l-Ascorbic Acid Potentiates Endothelial Nitric Oxide Synthesis via a Chemical Stabilization of Tetrahydrobiopterin* , 2001, The Journal of Biological Chemistry.
[22] Leslie A. Smith,et al. Gene transfer of recombinant endothelial nitric oxide synthase to liver in vivo and in vitro. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[23] R. Bataller,et al. Hepatocyte-derived cysteinyl leukotrienes modulate vascular tone in experimental cirrhosis. , 2000, Gastroenterology.
[24] R. Bataller,et al. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. , 2000, Gastroenterology.
[25] J. Keaney,et al. Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension. , 2000, Hypertension.
[26] D. Rockey,et al. Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hypertension. , 2000, The Journal of clinical investigation.
[27] M. Toruner,et al. Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat. , 1999, Gastroenterology.
[28] J. Keaney,et al. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. , 1998, Circulation research.
[29] T. Gupta,et al. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats , 1998, Hepatology.
[30] L. Ghiadoni,et al. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. , 1998, Circulation.
[31] D. Rockey,et al. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension. , 1998, Gastroenterology.
[32] B. Hornig,et al. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. , 1997, Circulation.
[33] T. Rabelink,et al. Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. , 1997, Biochemical and biophysical research communications.
[34] V. Paradis,et al. In situ detection of lipid peroxidation by‐products in chronic liver diseases , 1997, Hepatology.
[35] Farris K. Timimi,et al. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. , 1997, Circulation.
[36] G. Marchesini,et al. Glutathione kinetics in normal man and in patients with liver cirrhosis. , 1997, Journal of hepatology.
[37] D. Rockey,et al. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance , 1996, Hepatology.
[38] T. Gupta,et al. Nitric oxide modulates hepatic vascular tone in normal rat liver. , 1994, The American journal of physiology.
[39] M. Keogan,et al. Postprandial changes in portal haemodynamics in patients with cirrhosis. , 1992, Gut.
[40] N. Mcintyre,et al. The effect of non-protein liquid meals on the hepatic venous pressure gradient in patients with cirrhosis. , 1990, Journal of hepatology.
[41] M. Navasa,et al. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function. , 1989, Gastroenterology.
[42] S. Moncada,et al. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor , 1986, Nature.
[43] A. Federico,et al. Oxidative stress in viral and alcoholic hepatitis. , 2003, Free radical biology & medicine.
[44] J. Bosch,et al. Complications of cirrhosis. I. Portal hypertension. , 2000, Journal of hepatology.
[45] Farris K. Timimi,et al. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. , 1996, The Journal of clinical investigation.
[46] J. Calleja,et al. Octreotide prevents postprandial splanchnic hyperemia in patients with portal hypertension. , 1994, Journal of hepatology.
[47] J. Bruix,et al. Measurement of hepatic blood flow, hepatic extraction and intrinsic clearance of indocyanine green in patients with cirrhosis. Comparison of a non-invasive pharmacokinetic method with measurements using hepatic vein catheterization , 1991 .
[48] R. Groszmann,et al. Increased portal venous resistance hinders portal pressure reduction during the administration of β‐adrenergic blocking agents in a portal hypertensive model , 1985, Hepatology.
[49] P. Bhathal,et al. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators. , 1985, Journal of hepatology.